ADVERSA™
What It Does: Tracks rare post-vaccine or immune-triggered symptom clusters across populations and geographies.
Who It Serves: Regulatory agencies, pharmacovigilance units, maternal health researchers, and global safety boards.
Digital Product. No shipping.
This is a downloadable digital equity tool developed by CYNAERA. You'll receive access immediately after purchase.
-
Includes: Module file + usage guide + licensing terms
-
Format: PDF
-
Note: This is a digital tool. Refunds are not available after download. All sales final.
$199.00Price